When mRNA (messenger RNA) vaccines are injected into a patient, tiny lipid vesicles transport mRNA molecules through the body fluids and merge with immune cells, called antigen-presenting cells (APCs). mRNA vaccines work to instruct APCs to manufacture proteins called antigens that evoke an immune response to the threat.
Related CAS Insights
Crossing the Blood-Brain Barrier: Emerging Approaches for Drug Delivery
Why AI-Driven Drug Discovery Needs Biology Ontologies
Neuroinflammation Driving New Research Into Alzheimer’s and More
Gain new perspectives for faster progress directly to your inbox.
